Cargando…
Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders
In animal models of autism spectrum disorder (ASD), the NKCC1 chloride-importer inhibitor bumetanide restores physiological (Cl(−))(i) levels, enhances GABAergic inhibition and attenuates electrical and behavioral symptoms of ASD. In an earlier phase 2 trial; bumetanide reduced the severity of ASD i...
Autores principales: | Lemonnier, E, Villeneuve, N, Sonie, S, Serret, S, Rosier, A, Roue, M, Brosset, P, Viellard, M, Bernoux, D, Rondeau, S, Thummler, S, Ravel, D, Ben-Ari, Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5416661/ https://www.ncbi.nlm.nih.gov/pubmed/28291262 http://dx.doi.org/10.1038/tp.2017.10 |
Ejemplares similares
-
Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders
por: Lemonnier, E, et al.
Publicado: (2017) -
A randomised controlled trial of bumetanide in the treatment of autism in children
por: Lemonnier, E, et al.
Publicado: (2012) -
A Wholistic View of How Bumetanide Attenuates Autism Spectrum Disorders
por: Delpire, Eric, et al.
Publicado: (2022) -
Bumetanide for autism: more eye contact, less amygdala activation
por: Hadjikhani, Nouchine, et al.
Publicado: (2018) -
Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials)
por: Crutel, Véronique, et al.
Publicado: (2020)